Forefront is the complimentary magazine of the Mayo Clinic Cancer Center. Published in email and online newsletter editions quarterly, Forefront highlights Mayo Clinic’s cutting-edge cancer research and the latest Cancer Center news.
The September 2019 issue features:
- Director’s message: Recognition for a job well done
After a rigorous review, NCI has renewed Mayo Clinic Cancer Center’s elite designation and grant funding.
- Treatment of smoldering myeloma delays progression, study finds
Use of the drug lenalidomide instead of observation can delay symptom progression and organ damage.
- Discrimination, gender bias toward health care staff common
Cancer doctors face racism and gender disparity from both patients and colleagues, studies find.
- Breast cancer risk score buoys preventive medication use
A study that may change practice shows personal risk scores can encourage women to accept treatment.
- Researchers test electronic nose to screen for Barrett’s esophagus
A novel e-nose showed high accuracy, especially for patients taking high-dose proton pump inhibitors.
- Less-invasive mastectomy safe option for more breast cancer patients
Even women with locally advanced cancer or at risk of complications could have nipple-sparing surgery.
- 3 factors may extend survival in advanced pancreatic cancer
A different approach to chemotherapy before surgery and radiation boosted average survival to 58.8 months.
- Meet the investigator: Donald W. Northfelt, M.D.
In this Cancer Center video, Dr. Northfelt discusses breast cancer and equity in clinical trials.
Stay connected to Mayo Clinic Cancer Center